(Q61918085)
Statements
Treatment for Growth Failure in Patients With X-Linked Severe Combined Immunodeficiency (XSCID): A Phase 2 Study Assessing Safety and Clinical Response to Treatment With Insulin-like Growth Factor-1 (IGF-1) (English)
0 references
June 2007
0 references
December 2012
0 references
6
0 references
2 year
0 references
20 year
0 references